Cerus (CERS) FCF Margin Growth (3y) (2013 - 2026)
Cerus (CERS) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2,679.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -472.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -20.00 |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 6,534.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,534.00 |
| Dec 31, 2025 | 528.00 |
| Sep 30, 2025 | 4,011.00 |
| Jun 30, 2025 | -53,334.00 |
| Mar 31, 2025 | 14,351.00 |
| Dec 31, 2024 | 698.00 |
| Sep 30, 2024 | 59,513.00 |
| Jun 30, 2024 | 6,056.00 |
| Mar 31, 2024 | 18,486.00 |
| Dec 31, 2023 | 186.00 |
| Sep 30, 2023 | -661,634.00 |
| Jun 30, 2023 | 3,361.00 |
| Mar 31, 2023 | 637,886.00 |
| Dec 31, 2022 | 15,451.00 |
| Sep 30, 2022 | 570,009.00 |
| Jun 30, 2022 | 37,597.00 |
| Mar 31, 2022 | 41,445.00 |
| Dec 31, 2021 | 4,461.00 |
| Sep 30, 2021 | -7,905.00 |
| Jun 30, 2021 | 16,359.00 |